Global Crohn’s Disease Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Crohn’s Disease Therapeutics market size was valued at USD 3416.4 million in 2023 and is forecast to a readjusted size of USD 3750 million by 2030 with a CAGR of 1.3% during review period.
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Crohn’s Disease Therapeutics industry chain, the market status of Hospitals (Non-Surgical, Surgical), Ambulatory Surgical Centers (Non-Surgical, Surgical), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Crohn’s Disease Therapeutics.
Regionally, the report analyzes the Crohn’s Disease Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Crohn’s Disease Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Crohn’s Disease Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Crohn’s Disease Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Non-Surgical, Surgical).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Crohn’s Disease Therapeutics market.
Regional Analysis: The report involves examining the Crohn’s Disease Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Crohn’s Disease Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Crohn’s Disease Therapeutics:
Company Analysis: Report covers individual Crohn’s Disease Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Crohn’s Disease Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).
Technology Analysis: Report covers specific technologies relevant to Crohn’s Disease Therapeutics. It assesses the current state, advancements, and potential future developments in Crohn’s Disease Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Crohn’s Disease Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Crohn’s Disease Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Crohn’s Disease Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Crohn’s Disease Therapeutics, with revenue, gross margin and global market share of Crohn’s Disease Therapeutics from 2019 to 2024.
Chapter 3, the Crohn’s Disease Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Crohn’s Disease Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Crohn’s Disease Therapeutics.
Chapter 13, to describe Crohn’s Disease Therapeutics research findings and conclusion.
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Crohn’s Disease Therapeutics industry chain, the market status of Hospitals (Non-Surgical, Surgical), Ambulatory Surgical Centers (Non-Surgical, Surgical), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Crohn’s Disease Therapeutics.
Regionally, the report analyzes the Crohn’s Disease Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Crohn’s Disease Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Crohn’s Disease Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Crohn’s Disease Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Non-Surgical, Surgical).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Crohn’s Disease Therapeutics market.
Regional Analysis: The report involves examining the Crohn’s Disease Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Crohn’s Disease Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Crohn’s Disease Therapeutics:
Company Analysis: Report covers individual Crohn’s Disease Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Crohn’s Disease Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).
Technology Analysis: Report covers specific technologies relevant to Crohn’s Disease Therapeutics. It assesses the current state, advancements, and potential future developments in Crohn’s Disease Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Crohn’s Disease Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Crohn’s Disease Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Non-Surgical
- Surgical
- Hospitals
- Ambulatory Surgical Centers
- Johnson and Johnson Services Inc.
- Pfizer Inc.
- Allergan
- AbbVie Inc.
- Takeda Pharmaceutical Company Limited
- Celgene Corporation
- Perrigo Company PLC
- Ferring B.V.
- Salix Pharmaceuticals
- Gilead Sciences Inc.
- Genentech Inc.
- UCB India Private Limited.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Crohn’s Disease Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Crohn’s Disease Therapeutics, with revenue, gross margin and global market share of Crohn’s Disease Therapeutics from 2019 to 2024.
Chapter 3, the Crohn’s Disease Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Crohn’s Disease Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Crohn’s Disease Therapeutics.
Chapter 13, to describe Crohn’s Disease Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Crohn’s Disease Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Crohn’s Disease Therapeutics by Type
1.3.1 Overview: Global Crohn’s Disease Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Crohn’s Disease Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Non-Surgical
1.3.4 Surgical
1.4 Global Crohn’s Disease Therapeutics Market by Application
1.4.1 Overview: Global Crohn’s Disease Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.5 Global Crohn’s Disease Therapeutics Market Size & Forecast
1.6 Global Crohn’s Disease Therapeutics Market Size and Forecast by Region
1.6.1 Global Crohn’s Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Crohn’s Disease Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Crohn’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Crohn’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Crohn’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Crohn’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Crohn’s Disease Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Johnson and Johnson Services Inc.
2.1.1 Johnson and Johnson Services Inc. Details
2.1.2 Johnson and Johnson Services Inc. Major Business
2.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product and Solutions
2.1.4 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Johnson and Johnson Services Inc. Recent Developments and Future Plans
2.2 Pfizer Inc.
2.2.1 Pfizer Inc. Details
2.2.2 Pfizer Inc. Major Business
2.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Product and Solutions
2.2.4 Pfizer Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Inc. Recent Developments and Future Plans
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business
2.3.3 Allergan Crohn’s Disease Therapeutics Product and Solutions
2.3.4 Allergan Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Allergan Recent Developments and Future Plans
2.4 AbbVie Inc.
2.4.1 AbbVie Inc. Details
2.4.2 AbbVie Inc. Major Business
2.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Product and Solutions
2.4.4 AbbVie Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 AbbVie Inc. Recent Developments and Future Plans
2.5 Takeda Pharmaceutical Company Limited
2.5.1 Takeda Pharmaceutical Company Limited Details
2.5.2 Takeda Pharmaceutical Company Limited Major Business
2.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product and Solutions
2.5.4 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
2.6 Celgene Corporation
2.6.1 Celgene Corporation Details
2.6.2 Celgene Corporation Major Business
2.6.3 Celgene Corporation Crohn’s Disease Therapeutics Product and Solutions
2.6.4 Celgene Corporation Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Celgene Corporation Recent Developments and Future Plans
2.7 Perrigo Company PLC
2.7.1 Perrigo Company PLC Details
2.7.2 Perrigo Company PLC Major Business
2.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Product and Solutions
2.7.4 Perrigo Company PLC Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Perrigo Company PLC Recent Developments and Future Plans
2.8 Ferring B.V.
2.8.1 Ferring B.V. Details
2.8.2 Ferring B.V. Major Business
2.8.3 Ferring B.V. Crohn’s Disease Therapeutics Product and Solutions
2.8.4 Ferring B.V. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Ferring B.V. Recent Developments and Future Plans
2.9 Salix Pharmaceuticals
2.9.1 Salix Pharmaceuticals Details
2.9.2 Salix Pharmaceuticals Major Business
2.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Product and Solutions
2.9.4 Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Salix Pharmaceuticals Recent Developments and Future Plans
2.10 Gilead Sciences Inc.
2.10.1 Gilead Sciences Inc. Details
2.10.2 Gilead Sciences Inc. Major Business
2.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Product and Solutions
2.10.4 Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Gilead Sciences Inc. Recent Developments and Future Plans
2.11 Genentech Inc.
2.11.1 Genentech Inc. Details
2.11.2 Genentech Inc. Major Business
2.11.3 Genentech Inc. Crohn’s Disease Therapeutics Product and Solutions
2.11.4 Genentech Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Genentech Inc. Recent Developments and Future Plans
2.12 UCB India Private Limited.
2.12.1 UCB India Private Limited. Details
2.12.2 UCB India Private Limited. Major Business
2.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Product and Solutions
2.12.4 UCB India Private Limited. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 UCB India Private Limited. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Crohn’s Disease Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Crohn’s Disease Therapeutics by Company Revenue
3.2.2 Top 3 Crohn’s Disease Therapeutics Players Market Share in 2023
3.2.3 Top 6 Crohn’s Disease Therapeutics Players Market Share in 2023
3.3 Crohn’s Disease Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Crohn’s Disease Therapeutics Market: Region Footprint
3.3.2 Crohn’s Disease Therapeutics Market: Company Product Type Footprint
3.3.3 Crohn’s Disease Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Crohn’s Disease Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Crohn’s Disease Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Crohn’s Disease Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Crohn’s Disease Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Crohn’s Disease Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Crohn’s Disease Therapeutics Market Size by Country
6.3.1 North America Crohn’s Disease Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Crohn’s Disease Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Crohn’s Disease Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Crohn’s Disease Therapeutics Market Size by Country
7.3.1 Europe Crohn’s Disease Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region
8.3.1 Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Crohn’s Disease Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Crohn’s Disease Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Crohn’s Disease Therapeutics Market Size by Country
9.3.1 South America Crohn’s Disease Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country
10.3.1 Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Crohn’s Disease Therapeutics Market Drivers
11.2 Crohn’s Disease Therapeutics Market Restraints
11.3 Crohn’s Disease Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Crohn’s Disease Therapeutics Industry Chain
12.2 Crohn’s Disease Therapeutics Upstream Analysis
12.3 Crohn’s Disease Therapeutics Midstream Analysis
12.4 Crohn’s Disease Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Crohn’s Disease Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Crohn’s Disease Therapeutics by Type
1.3.1 Overview: Global Crohn’s Disease Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Crohn’s Disease Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Non-Surgical
1.3.4 Surgical
1.4 Global Crohn’s Disease Therapeutics Market by Application
1.4.1 Overview: Global Crohn’s Disease Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.5 Global Crohn’s Disease Therapeutics Market Size & Forecast
1.6 Global Crohn’s Disease Therapeutics Market Size and Forecast by Region
1.6.1 Global Crohn’s Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Crohn’s Disease Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Crohn’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Crohn’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Crohn’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Crohn’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Crohn’s Disease Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Johnson and Johnson Services Inc.
2.1.1 Johnson and Johnson Services Inc. Details
2.1.2 Johnson and Johnson Services Inc. Major Business
2.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product and Solutions
2.1.4 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Johnson and Johnson Services Inc. Recent Developments and Future Plans
2.2 Pfizer Inc.
2.2.1 Pfizer Inc. Details
2.2.2 Pfizer Inc. Major Business
2.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Product and Solutions
2.2.4 Pfizer Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Inc. Recent Developments and Future Plans
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business
2.3.3 Allergan Crohn’s Disease Therapeutics Product and Solutions
2.3.4 Allergan Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Allergan Recent Developments and Future Plans
2.4 AbbVie Inc.
2.4.1 AbbVie Inc. Details
2.4.2 AbbVie Inc. Major Business
2.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Product and Solutions
2.4.4 AbbVie Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 AbbVie Inc. Recent Developments and Future Plans
2.5 Takeda Pharmaceutical Company Limited
2.5.1 Takeda Pharmaceutical Company Limited Details
2.5.2 Takeda Pharmaceutical Company Limited Major Business
2.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product and Solutions
2.5.4 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
2.6 Celgene Corporation
2.6.1 Celgene Corporation Details
2.6.2 Celgene Corporation Major Business
2.6.3 Celgene Corporation Crohn’s Disease Therapeutics Product and Solutions
2.6.4 Celgene Corporation Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Celgene Corporation Recent Developments and Future Plans
2.7 Perrigo Company PLC
2.7.1 Perrigo Company PLC Details
2.7.2 Perrigo Company PLC Major Business
2.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Product and Solutions
2.7.4 Perrigo Company PLC Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Perrigo Company PLC Recent Developments and Future Plans
2.8 Ferring B.V.
2.8.1 Ferring B.V. Details
2.8.2 Ferring B.V. Major Business
2.8.3 Ferring B.V. Crohn’s Disease Therapeutics Product and Solutions
2.8.4 Ferring B.V. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Ferring B.V. Recent Developments and Future Plans
2.9 Salix Pharmaceuticals
2.9.1 Salix Pharmaceuticals Details
2.9.2 Salix Pharmaceuticals Major Business
2.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Product and Solutions
2.9.4 Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Salix Pharmaceuticals Recent Developments and Future Plans
2.10 Gilead Sciences Inc.
2.10.1 Gilead Sciences Inc. Details
2.10.2 Gilead Sciences Inc. Major Business
2.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Product and Solutions
2.10.4 Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Gilead Sciences Inc. Recent Developments and Future Plans
2.11 Genentech Inc.
2.11.1 Genentech Inc. Details
2.11.2 Genentech Inc. Major Business
2.11.3 Genentech Inc. Crohn’s Disease Therapeutics Product and Solutions
2.11.4 Genentech Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Genentech Inc. Recent Developments and Future Plans
2.12 UCB India Private Limited.
2.12.1 UCB India Private Limited. Details
2.12.2 UCB India Private Limited. Major Business
2.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Product and Solutions
2.12.4 UCB India Private Limited. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 UCB India Private Limited. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Crohn’s Disease Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Crohn’s Disease Therapeutics by Company Revenue
3.2.2 Top 3 Crohn’s Disease Therapeutics Players Market Share in 2023
3.2.3 Top 6 Crohn’s Disease Therapeutics Players Market Share in 2023
3.3 Crohn’s Disease Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Crohn’s Disease Therapeutics Market: Region Footprint
3.3.2 Crohn’s Disease Therapeutics Market: Company Product Type Footprint
3.3.3 Crohn’s Disease Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Crohn’s Disease Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Crohn’s Disease Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Crohn’s Disease Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Crohn’s Disease Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Crohn’s Disease Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Crohn’s Disease Therapeutics Market Size by Country
6.3.1 North America Crohn’s Disease Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Crohn’s Disease Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Crohn’s Disease Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Crohn’s Disease Therapeutics Market Size by Country
7.3.1 Europe Crohn’s Disease Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region
8.3.1 Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Crohn’s Disease Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Crohn’s Disease Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Crohn’s Disease Therapeutics Market Size by Country
9.3.1 South America Crohn’s Disease Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country
10.3.1 Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Crohn’s Disease Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Crohn’s Disease Therapeutics Market Drivers
11.2 Crohn’s Disease Therapeutics Market Restraints
11.3 Crohn’s Disease Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Crohn’s Disease Therapeutics Industry Chain
12.2 Crohn’s Disease Therapeutics Upstream Analysis
12.3 Crohn’s Disease Therapeutics Midstream Analysis
12.4 Crohn’s Disease Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Crohn’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Crohn’s Disease Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Crohn’s Disease Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Crohn’s Disease Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Johnson and Johnson Services Inc. Company Information, Head Office, and Major Competitors
Table 6. Johnson and Johnson Services Inc. Major Business
Table 7. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 8. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Johnson and Johnson Services Inc. Recent Developments and Future Plans
Table 10. Pfizer Inc. Company Information, Head Office, and Major Competitors
Table 11. Pfizer Inc. Major Business
Table 12. Pfizer Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 13. Pfizer Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Inc. Recent Developments and Future Plans
Table 15. Allergan Company Information, Head Office, and Major Competitors
Table 16. Allergan Major Business
Table 17. Allergan Crohn’s Disease Therapeutics Product and Solutions
Table 18. Allergan Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Allergan Recent Developments and Future Plans
Table 20. AbbVie Inc. Company Information, Head Office, and Major Competitors
Table 21. AbbVie Inc. Major Business
Table 22. AbbVie Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 23. AbbVie Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. AbbVie Inc. Recent Developments and Future Plans
Table 25. Takeda Pharmaceutical Company Limited Company Information, Head Office, and Major Competitors
Table 26. Takeda Pharmaceutical Company Limited Major Business
Table 27. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product and Solutions
Table 28. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
Table 30. Celgene Corporation Company Information, Head Office, and Major Competitors
Table 31. Celgene Corporation Major Business
Table 32. Celgene Corporation Crohn’s Disease Therapeutics Product and Solutions
Table 33. Celgene Corporation Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Celgene Corporation Recent Developments and Future Plans
Table 35. Perrigo Company PLC Company Information, Head Office, and Major Competitors
Table 36. Perrigo Company PLC Major Business
Table 37. Perrigo Company PLC Crohn’s Disease Therapeutics Product and Solutions
Table 38. Perrigo Company PLC Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Perrigo Company PLC Recent Developments and Future Plans
Table 40. Ferring B.V. Company Information, Head Office, and Major Competitors
Table 41. Ferring B.V. Major Business
Table 42. Ferring B.V. Crohn’s Disease Therapeutics Product and Solutions
Table 43. Ferring B.V. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Ferring B.V. Recent Developments and Future Plans
Table 45. Salix Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Salix Pharmaceuticals Major Business
Table 47. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product and Solutions
Table 48. Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Salix Pharmaceuticals Recent Developments and Future Plans
Table 50. Gilead Sciences Inc. Company Information, Head Office, and Major Competitors
Table 51. Gilead Sciences Inc. Major Business
Table 52. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 53. Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Gilead Sciences Inc. Recent Developments and Future Plans
Table 55. Genentech Inc. Company Information, Head Office, and Major Competitors
Table 56. Genentech Inc. Major Business
Table 57. Genentech Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 58. Genentech Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Genentech Inc. Recent Developments and Future Plans
Table 60. UCB India Private Limited. Company Information, Head Office, and Major Competitors
Table 61. UCB India Private Limited. Major Business
Table 62. UCB India Private Limited. Crohn’s Disease Therapeutics Product and Solutions
Table 63. UCB India Private Limited. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. UCB India Private Limited. Recent Developments and Future Plans
Table 65. Global Crohn’s Disease Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 66. Global Crohn’s Disease Therapeutics Revenue Share by Players (2019-2024)
Table 67. Breakdown of Crohn’s Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Crohn’s Disease Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Crohn’s Disease Therapeutics Players
Table 70. Crohn’s Disease Therapeutics Market: Company Product Type Footprint
Table 71. Crohn’s Disease Therapeutics Market: Company Product Application Footprint
Table 72. Crohn’s Disease Therapeutics New Market Entrants and Barriers to Market Entry
Table 73. Crohn’s Disease Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Crohn’s Disease Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Crohn’s Disease Therapeutics Consumption Value Share by Type (2019-2024)
Table 76. Global Crohn’s Disease Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 77. Global Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024)
Table 78. Global Crohn’s Disease Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 79. North America Crohn’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Crohn’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Crohn’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Crohn’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Crohn’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Crohn’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Crohn’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Crohn’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Crohn’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Crohn’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Crohn’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Crohn’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Crohn’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Crohn’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Crohn’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Crohn’s Disease Therapeutics Raw Material
Table 110. Key Suppliers of Crohn’s Disease Therapeutics Raw Materials
Table 1. Global Crohn’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Crohn’s Disease Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Crohn’s Disease Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Crohn’s Disease Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Johnson and Johnson Services Inc. Company Information, Head Office, and Major Competitors
Table 6. Johnson and Johnson Services Inc. Major Business
Table 7. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 8. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Johnson and Johnson Services Inc. Recent Developments and Future Plans
Table 10. Pfizer Inc. Company Information, Head Office, and Major Competitors
Table 11. Pfizer Inc. Major Business
Table 12. Pfizer Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 13. Pfizer Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Inc. Recent Developments and Future Plans
Table 15. Allergan Company Information, Head Office, and Major Competitors
Table 16. Allergan Major Business
Table 17. Allergan Crohn’s Disease Therapeutics Product and Solutions
Table 18. Allergan Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Allergan Recent Developments and Future Plans
Table 20. AbbVie Inc. Company Information, Head Office, and Major Competitors
Table 21. AbbVie Inc. Major Business
Table 22. AbbVie Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 23. AbbVie Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. AbbVie Inc. Recent Developments and Future Plans
Table 25. Takeda Pharmaceutical Company Limited Company Information, Head Office, and Major Competitors
Table 26. Takeda Pharmaceutical Company Limited Major Business
Table 27. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product and Solutions
Table 28. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
Table 30. Celgene Corporation Company Information, Head Office, and Major Competitors
Table 31. Celgene Corporation Major Business
Table 32. Celgene Corporation Crohn’s Disease Therapeutics Product and Solutions
Table 33. Celgene Corporation Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Celgene Corporation Recent Developments and Future Plans
Table 35. Perrigo Company PLC Company Information, Head Office, and Major Competitors
Table 36. Perrigo Company PLC Major Business
Table 37. Perrigo Company PLC Crohn’s Disease Therapeutics Product and Solutions
Table 38. Perrigo Company PLC Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Perrigo Company PLC Recent Developments and Future Plans
Table 40. Ferring B.V. Company Information, Head Office, and Major Competitors
Table 41. Ferring B.V. Major Business
Table 42. Ferring B.V. Crohn’s Disease Therapeutics Product and Solutions
Table 43. Ferring B.V. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Ferring B.V. Recent Developments and Future Plans
Table 45. Salix Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Salix Pharmaceuticals Major Business
Table 47. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product and Solutions
Table 48. Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Salix Pharmaceuticals Recent Developments and Future Plans
Table 50. Gilead Sciences Inc. Company Information, Head Office, and Major Competitors
Table 51. Gilead Sciences Inc. Major Business
Table 52. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 53. Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Gilead Sciences Inc. Recent Developments and Future Plans
Table 55. Genentech Inc. Company Information, Head Office, and Major Competitors
Table 56. Genentech Inc. Major Business
Table 57. Genentech Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 58. Genentech Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Genentech Inc. Recent Developments and Future Plans
Table 60. UCB India Private Limited. Company Information, Head Office, and Major Competitors
Table 61. UCB India Private Limited. Major Business
Table 62. UCB India Private Limited. Crohn’s Disease Therapeutics Product and Solutions
Table 63. UCB India Private Limited. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. UCB India Private Limited. Recent Developments and Future Plans
Table 65. Global Crohn’s Disease Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 66. Global Crohn’s Disease Therapeutics Revenue Share by Players (2019-2024)
Table 67. Breakdown of Crohn’s Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Crohn’s Disease Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Crohn’s Disease Therapeutics Players
Table 70. Crohn’s Disease Therapeutics Market: Company Product Type Footprint
Table 71. Crohn’s Disease Therapeutics Market: Company Product Application Footprint
Table 72. Crohn’s Disease Therapeutics New Market Entrants and Barriers to Market Entry
Table 73. Crohn’s Disease Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Crohn’s Disease Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Crohn’s Disease Therapeutics Consumption Value Share by Type (2019-2024)
Table 76. Global Crohn’s Disease Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 77. Global Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024)
Table 78. Global Crohn’s Disease Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 79. North America Crohn’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Crohn’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Crohn’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Crohn’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Crohn’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Crohn’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Crohn’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Crohn’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Crohn’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Crohn’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Crohn’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Crohn’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Crohn’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Crohn’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Crohn’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Crohn’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Crohn’s Disease Therapeutics Raw Material
Table 110. Key Suppliers of Crohn’s Disease Therapeutics Raw Materials
LIST OF FIGURES
Figure 1. Crohn’s Disease Therapeutics Picture
Figure 2. Global Crohn’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Crohn’s Disease Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Non-Surgical
Figure 5. Surgical
Figure 6. Global Crohn’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Crohn’s Disease Therapeutics Consumption Value Market Share by Application in 2023
Figure 8. Hospitals Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Global Crohn’s Disease Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Crohn’s Disease Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Crohn’s Disease Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Crohn’s Disease Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Crohn’s Disease Therapeutics Consumption Value Market Share by Region in 2023
Figure 15. North America Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Crohn’s Disease Therapeutics Revenue Share by Players in 2023
Figure 21. Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Crohn’s Disease Therapeutics Market Share in 2023
Figure 23. Global Top 6 Players Crohn’s Disease Therapeutics Market Share in 2023
Figure 24. Global Crohn’s Disease Therapeutics Consumption Value Share by Type (2019-2024)
Figure 25. Global Crohn’s Disease Therapeutics Market Share Forecast by Type (2025-2030)
Figure 26. Global Crohn’s Disease Therapeutics Consumption Value Share by Application (2019-2024)
Figure 27. Global Crohn’s Disease Therapeutics Market Share Forecast by Application (2025-2030)
Figure 28. North America Crohn’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Crohn’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Crohn’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Crohn’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 38. France Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 45. China Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. India Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Crohn’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Crohn’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Crohn’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Crohn’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 62. Crohn’s Disease Therapeutics Market Drivers
Figure 63. Crohn’s Disease Therapeutics Market Restraints
Figure 64. Crohn’s Disease Therapeutics Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Crohn’s Disease Therapeutics in 2023
Figure 67. Manufacturing Process Analysis of Crohn’s Disease Therapeutics
Figure 68. Crohn’s Disease Therapeutics Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Crohn’s Disease Therapeutics Picture
Figure 2. Global Crohn’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Crohn’s Disease Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Non-Surgical
Figure 5. Surgical
Figure 6. Global Crohn’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Crohn’s Disease Therapeutics Consumption Value Market Share by Application in 2023
Figure 8. Hospitals Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Global Crohn’s Disease Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Crohn’s Disease Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Crohn’s Disease Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Crohn’s Disease Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Crohn’s Disease Therapeutics Consumption Value Market Share by Region in 2023
Figure 15. North America Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Crohn’s Disease Therapeutics Revenue Share by Players in 2023
Figure 21. Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Crohn’s Disease Therapeutics Market Share in 2023
Figure 23. Global Top 6 Players Crohn’s Disease Therapeutics Market Share in 2023
Figure 24. Global Crohn’s Disease Therapeutics Consumption Value Share by Type (2019-2024)
Figure 25. Global Crohn’s Disease Therapeutics Market Share Forecast by Type (2025-2030)
Figure 26. Global Crohn’s Disease Therapeutics Consumption Value Share by Application (2019-2024)
Figure 27. Global Crohn’s Disease Therapeutics Market Share Forecast by Application (2025-2030)
Figure 28. North America Crohn’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Crohn’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Crohn’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Crohn’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 38. France Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Crohn’s Disease Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 45. China Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. India Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Crohn’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Crohn’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Crohn’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Crohn’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Crohn’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Crohn’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 62. Crohn’s Disease Therapeutics Market Drivers
Figure 63. Crohn’s Disease Therapeutics Market Restraints
Figure 64. Crohn’s Disease Therapeutics Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Crohn’s Disease Therapeutics in 2023
Figure 67. Manufacturing Process Analysis of Crohn’s Disease Therapeutics
Figure 68. Crohn’s Disease Therapeutics Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
